Occurrence and clinical management of moderate-to-severe adverse events during drug-resistant tuberculosis treatment: a retrospective cohort study

Por Sagwa, Evans L, Mantel-Teeuwisse, Aukje K, Ruswa, Nunurai C
Publicado no J Pharm Policy Pract (2014)

Availability, prices and affordability of UN Commission’s lifesaving medicines for reproductive and maternal health in Uganda

Por Kibira, Denis, Kitutu, Freddy Eric, Merrett, Gemma Buckland, Mantel-Teeuwisse, Aukje K.
Publicado no J Pharm Policy Pract (2017)

Future of the European Union regulatory network in the context of the uptake of new medicines

Por Hoebert, Joëlle M, Irs, Alar, Mantel-Teeuwisse, Aukje K, Leufkens, Hubert G M
Publicado em 2013

Selection of Essential Medicines for Diabetes in Low and Middle Income Countries: A Survey of 32 National Essential Medicines Lists

Por Bazargani, Yaser T., de Boer, Anthonius, Leufkens, Hubert G. M., Mantel-Teeuwisse, Aukje K.
Publicado em 2014

Characteristics of drugs safety signals that predict safety related product information update

Por Insani, Widya N., Pacurariu, Alexandra C., Mantel‐Teeuwisse, Aukje K., Gross‐Martirosyan, Liana
Publicado no Pharmacoepidemiol Drug Saf (2018)

The double opioid crisis: A call for balance

Por Vranken, Marjolein J.M., Schutjens, Marie‐Hélène D.B., Mantel‐Teeuwisse, Aukje K.
Publicado no Pharmacoepidemiol Drug Saf (2019)

Systematic reviews of ten pharmaceutical pricing policies – a research protocol

Por Tordrup, David, van den Ham, Hendrika A., Glanville, Julie, Mantel-Teeuwisse, Aukje K.
Publicado no J Pharm Policy Pract (2020)

Price changes of antibiotics and perceived substitutes in the context of OTC policy changes in Mexico and Brazil

Por Santa-Ana-Tellez, Yared, Wirtz, Veronika J, Leufkens, Hubert GM, Mantel-Teeuwisse, Aukje K
Publicado no J Pharm Policy Pract (2015)

Five-year trends in treatment changes in an adult cohort of HIV/AIDS patients in Ghana: a retrospective cohort study

Por Ankrah, Daniel N. A., Lartey, Margaret, Mantel-Teeuwisse, Aukje K., Leufkens, Hubert G. M.
Publicado no BMC Infect Dis (2017)

Essential Medicines Are More Available than Other Medicines around the Globe

Por Bazargani, Yaser T., Ewen, Margaret, de Boer, Anthonius, Leufkens, Hubert G. M., Mantel-Teeuwisse, Aukje K.
Publicado em 2014

Seasonal Variation in Penicillin Use in Mexico and Brazil: Analysis of the Impact of Over-the-Counter Restrictions

Por Santa-Ana-Tellez, Yared, Mantel-Teeuwisse, Aukje K., Leufkens, Hubert G. M., Wirtz, Veronika J.
Publicado no Antimicrob Agents Chemother (2014)

Reply to “Decrease in Penicillin Sales in Brazil after Over-the-Counter Restrictions”

Por Santa-Ana-Tellez, Yared, Mantel-Teeuwisse, Aukje K., Leufkens, Hubert G. M., Wirtz, Veronika J.
Publicado no Antimicrob Agents Chemother (2015)

Recent trends in (under)treatment of hypercholesterolaemia in the Netherlands

Por Mantel-Teeuwisse, Aukje K, Verschuren, W M Monique, Klungel, Olaf H, de Boer, Anthonius, Kromhout, Daan
Publicado em 2004

Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries

Por Cameron, Alexandra, Roubos, Ilse, Ewen, Margaret, Mantel-Teeuwisse, Aukje K, Leufkens, Hubertus GM, Laing, Richard O
Publicado em 2011

National medicines policies – a review of the evolution and development processes

Por Hoebert, Joëlle M, van Dijk, Liset, Mantel-Teeuwisse, Aukje K, Leufkens, Hubert GM, Laing, Richard O
Publicado em 2013

Characteristics and follow‐up of postmarketing studies of conditionally authorized medicines in the EU

Por Hoekman, Jarno, Klamer, Thea T., Mantel‐Teeuwisse, Aukje K., Leufkens, Hubert G. M., De Bruin, Marie L.
Publicado no Br J Clin Pharmacol (2016)

Adverse events and patients’ perceived health-related quality of life at the end of multidrug-resistant tuberculosis treatment in Namibia

Por Sagwa, Evans L, Ruswa, Nunurai, Mavhunga, Farai, Rennie, Timothy, Leufkens, Hubert GM, Mantel-Teeuwisse, Aukje K
Publicado no Patient Prefer Adherence (2016)

The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study

Por Jacobs, Tom G., Hilda Ampadu, H., Hoekman, Jarno, Dodoo, Alexander N. O., Mantel-Teeuwisse, Aukje K.
Publicado no BMC Public Health (2018)

Time trends in lipid lowering drug use in The Netherlands. Has the backlog of candidates for treatment been eliminated?

Por Mantel-Teeuwisse, Aukje K, Klungel, Olaf H, Verschuren, W M Monique, Porsius, Arijan J, de Boer, Anthonius
Publicado em 2002

Regulatory scientific advice in drug development: does company size make a difference?

Por Putzeist, Michelle, Mantel-Teeuwisse, Aukje K., Gispen-De Wied, Christine C., Hoes, Arno W., Leufkens, Hubert G.
Publicado em 2010